Intimation of Press Release

Registered Office: 103, Akruti Arcade, Opposite A H Wadia High School, Near Azad Nagar Metro Station, Andheri (West), Mumbai –400058. Tel: 022 61437991 | Email: info@laxmidentallimited.com | Website: www.laxmidentallimited.com CIN No: L51507MH2004PLC147394 | GST No: 27AABCL0001A1ZL Date: August 11, 2026 Listing Department Listing & Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Mumbai – 400001 Plot No. C/1, “G” Block BSE Scrip Code: 544339 Bandra-Kurla Complex Bandra (E), Mumbai – 400 051 Symbol: LAXMIDENTL Re: LAXMI DENTAL LIMITED - ISIN: INE0WO601020 Dear Sir(s)/Madam(s), Sub: Intimation of Press Release on Unaudited Consolidated Financial Results for the quarter ended June 30, 2026 of Laxmi Dental Limited (“the Company”). Pursuant to the provisions of Regulation 30 read with Schedule III Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, we enclose herewith a press release, being issued by the Company on the Unaudited Consolidated Financial Results of the Company for quarter ended on June 30, 2026. The same shall also be uploaded on website of the Company at https://www.laxmidentallimited.com/for- investors Kindly take the above on record. For Laxmi Dental Limited -------------------------------------------------- Suman Saha Company Secretary and Compliance Officer ICSI Membership Number: A33035 Encl.: As above. Earnings Release Laxmi Dental Limited Q1 FY27 Consolidated Results Tuesday, 11th August 2026, Mumbai – Laxmi Dental Limited (BSE - 544339, NSE – LAXMIDENTL), a leading integrated dental products company, announced its unaudited Financial Results for the quarter ended June 30th, 2026. Consolidated Result Highlights Consolidated P&L (INR Mn) Q1FY27 Q1FY26 YoY Q4FY26 Q-o-Q FY26 Revenues1 747.0 656.0 13.9% 739.5 1.0% 2,778.6 EBITDA 143.6 119.1 20.6% 135.0 6.4% 434.0 EBITDA Margin 19.2% 18.2% 18.3% 15.6% Profit before Tax and Exceptional Items 120.4 95.9 25.5% 111.4 8.1% 347.0 Exceptional Items 0.0 0.0 0.0 -57.8 Profit before Tax 120.4 95.9 25.5% 111.4 8.1% 289.3 PAT after share of profit/loss from JVs 103.2 83.3 23.8% 100.9 2.2% 289.2 PAT Margin 13.8% 12.7% 13.6% 10.4% Adjusted EBITDA2 159.6 147.7 8.0% 130.9 21.9% 511.5 Notes: 1. As per Ind AS norms revenue does not include revenue from Kids-e-Dental and IDBG AI Dent as they are jointly controlled entity. 2. Adjusted EBITDA is calculated as Reported EBITDA + ESOP expenses (non-cash in nature). + 60% of Kids-e-dental PAT + 49% of IDBG AI Dent PAT. Q1FY27 Performance Highlights: • Highest-ever quarterly revenue with 13.9% YoY growth. • Gross margins stood at 78.6%, which is a year-on-year and sequential improvement; driven by change in product mix. o Gross Margins for the Core Dental Business excluding scanner sales has marginally improved. o Scanner sales contribution for the quarter was minimal. • Sequential increase in employee costs is mainly due to appointment of new CEO for USA business and addition of people in sales and other important areas. • ESOP expenses, which are non-cash in nature, amounted to INR 8.3 Mn in Q1FY27 as against INR 18.4 Mn in Q1FY26. • Other expenses increased largely on account of higher freight cost and ECL (provisions) as well as spending towards AI led automation initiatives which are important for efficient scalability in future. Earnings Release Management Commentary Commenting on the performance Mr. Rajesh Khakhar, Chairperson and Whole-Time Director said, “We are pleased to report a strong start to FY27, with Q1 revenue reaching our highest-ever quarterly level of around ₹75.0 crore, representing year-on-year growth of 13.9%. The performance was broad-based, led by healthy momentum in our Dental Laboratory business and our Aligner Solutions business. Our profitability during the quarter witnessed some improvement largely on account of a better product mix. We are strengthening our on-ground leadership presence in the U.S. to sharpen our market-focused strategy and sustain healthy growth in this market. In India, we have established 3 new support facilities across multiple cities to deepen our regional presence, enhance market penetration and provide better service to our existing dental partners. Going forward, a focus on core dental portfolio, deeper market penetration, AI-led automation, and improving operational efficiencies enables Laxmi Dental to deliver healthy and sustainable performance.” Commenting on the performance Mr. Sameer Merchant, Managing Director and CEO said, “Our robust performance in Q1FY27 reflects the sustained efforts of our sales and operations teams, supported by scanner deployments in the past, training programs, promotional activities, participation in dental events and digital initiatives. For the quarter our dental laboratory business grew by 23.5% year-on-year, with international operations registering particularly strong growth of 37.4%, reflecting our relationships and market presence across global markets. Aligner Solutions business also maintained its momentum, growing 28.6% year-on-year, with both Bizdent and Vedia delivering healthy growth of 27.8% and 29.3% respectively. With continued progress in digitalization, innovation, branding and dental network expansion, we remain well positioned to deliver sustainable and profitable growth for the upcoming years.” Earnings Release About Laxmi Dental Limited Incorporated in 2004, Laxmi Dental Ltd is an integrated dental products company offering a comprehensive portfolio of dental products. It is India’s only end-to-end integrated dental products company as of September, 2024 (Source: F&S Report). It is also the largest exporter among the Indian dental labs, in terms of export value as of December 2023 with presence in 95+ countries (Source: F&S Report). The company’s offerings include custom-made crowns and bridges, branded dental products such as clear aligners, thermoforming sheets, and aligner related products as a part of aligner solutions, and pediatric dental products. The company manufactures dental products across its six manufacturing facilities, three of which are located in Mira Road, Mumbai Metropolitan Region, Maharashtra, two in Boisar, Mumbai Metropolitan Region, Maharashtra, and one in Kochi, Kerala, and further five supporting facilities two of which are located in Mumbai, and one each in Delhi, Bengaluru, and Ahmedabad with manufacturing capabilities. For more information about the company and its businesses, please visit www.laxmidentallimited.com Safe Harbour Statement: Statements in this document relating to future status, events, or circumstances, including but not limited to statements about plans and objectives, the progress and results of research and development, potential project characteristics, project potential and target dates for project related issues are forward-looking statements based on estimates and the anticipated effects of future events on current and developing circumstances. Such statements are subject to numerous risks and uncertainties and are not necessarily predictive of future results. Actual results may differ materially from those anticipated in the forward-looking statements. The company assumes no obligation to update forward-looking statements to reflect actual results changed assumptions or other factors. Earnings Release For more information please contact: Laxmi Dental Limited Strategic Growth Advisors Pvt Ltd. CIN: L51507MH2004PLC147394 CIN: U74140MH2010PTC204285 Mr. Suman Saha Dharmik Kansara/ Shikha Puri Email id: co.sec@laxmidentallimited.com Email id: dharmik.k@sgapl.net/ shikha.puri@sgapl.net Tel No: +91 7208179323/ +91 9819282743